Ruth Alon insider trades

Open-market stock purchases and sales by Ruth Alon, Director at Silexion Therapeutics Corp, from SEC Form 4 filings since Feb 9, 2025.

Recent trades

DateStockTradeValue
Feb 20, 2026SLXN Silexion Therapeutics CorpBought (not open market)—
Feb 20, 2026SLXN Silexion Therapeutics CorpBought (not open market)—

Companies traded

  • SLXN Silexion Therapeutics Corp: other filings, last Feb 20, 2026

Get free alerts when Ruth Alon files a new trade →